Abstract:A comprehensive summary of recent advances in SARS‐CoV‐2 3CLpro inhibitors (including marketed drugs, peptidomimetic, and non‐peptidomimetic synthetic compounds, as well as natural compounds and their derivatives), including the inhibitory activities, inhibitory mechanisms, and key structural features, provides new insights for designing and developing more efficacious 3CLpro inhibitors as broad‐spectrum anti‐coronavirus agents. The main proteases (Mpro), also termed 3‐chymotrypsin‐like proteases (3CLpro), are a class of highly conserved cysteine hydrolases in β‐coronaviruses. Increasing evidence has demonstrated that 3CLpros play an indispensable role in viral replication and have been recognized as key targets for preventing and treating coronavirus‐caused infectious diseases, including COVID‐19. This review is focused on the structural features and biological function of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) main protease Mpro (also known as 3CLpro), as well as recent advances in discovering and developing SARS‐CoV‐2 3CLpro inhibitors. To better understand the characteristics of SARS‐CoV‐2 3CLpro inhibitors, the inhibition activities, inhibitory mechanisms, and key structural features of various 3CLpro inhibitors (including marketed drugs, peptidomimetic, and non‐peptidomimetic synthetic compounds, as well as natural compounds and their derivatives) are summarized comprehensively. Meanwhile, the challenges in this field are highlighted, while future directions for designing and developing efficacious 3CLpro inhibitors as novel anti‐coronavirus therapies are also proposed. Collectively, all information and knowledge presented here are very helpful for understanding the structural features and inhibitory mechanisms of SARS‐CoV‐2 3CLpro inhibitors, which offers new insights or inspiration to medicinal chemists for designing and developing more efficacious 3CLpro inhibitors as novel anti‐coronavirus agents.

Structure and Dynamics of SARS Coronavirus Main Proteinase (Mpro).

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

The R Protein of SARS-CoV: Analyses of Structure and Function Based on Four Complete Genome Sequences of Isolates BJ01-BJ04

1 H, 13 C and 15 N resonance assignments of SARS-CoV main protease N-terminal domain

Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2

C-Terminal Domain of Sars-Cov Main Protease Can Form A 3d Domain-Swapped Dimer

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19

1H, 13C, and 15N Resonance Assignments of the N-terminal Domain of the SARS CoV Nucleocapsid Protein.

Activation and Maturation of Sars-Cov Main Protease

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism

Structure of the Multiple Functional Domains from Coronavirus Nonstructural Protein 3

Without Its N-Finger, the Main Protease of Severe Acute Respiratory Syndrome Coronavirus Can Form a Novel Dimer Through Its C-Terminal Domain

Structure and Functions of Papain-like Protease of Severe Acute Respiratory Syndrome(SARS) Coronavirus

Ph-Dependent Conformational Flexibility of the SARS-CoV Main Proteinase (mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses

Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme

An Extended Conformation of SARS-CoV-2 Main Protease Reveals Allosteric Targets.

Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-Like Proteinase.

The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5′ to 3′ Viral Helicases

Optimization of the Expression of the Main Protease from SARS-CoV-2.

The Crystal Structures of Severe Acute Respiratory Syndrome Virus Main Protease and Its Complex with an Inhibitor